Lectin-like oxyLDL receptor-1 (LOX-1) has recently been suggested to be involved in smooth muscle cell (SMC) proliferation and neointima formation in injured blood vessels. This study evaluates the effect of the nonvolatile fraction (NVF), the antioxidant component of bergamot essential oil (BEO), on LOX-1 expression and free radical generation in a model of rat angioplasty. Common carotid arteries injured by balloon angioplasty were removed after 14 days for histopathological, biochemical, and immunohistochemical studies. Balloon injury led to a significant restenosis with SMC proliferation and neointima formation, accompanied by increased expression of LOX-1 receptor, malondialdehyde and superoxide formation, and nitrotyrosine staining. Pretreatment of rats with BEO-NVF reduced the neointima proliferation together with free radical formation and LOX-1 expression in a dose-dependent manner. These results suggest that natural antioxidants may be relevant in the treatment of vascular disorders in which proliferation of SMCs and oxyLDL-related endothelial cell dysfunction are involved.
Carter AJ, Laird JR, Farb A., et al. Morphologic characteristics of lesion formation and time course of SMC proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol. 1994;24:1398-405.
2.
Indolfi C., Esposito G., Di Lorenzo E., et al. SMC proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. Circulation. 1995;92:1230-1235.
3.
Hoffmann R., Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation. 1996;94:1247-1254.
4.
Roubin GS, Cannon AD, Agrawal SK, et al. Intracoronary stenting for acute or threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation . 1992;85:916-927.
5.
Indolfi C., Stabile E., Perrino C., Chiariello M.Mechanisms of restenosis after angioplasty and approach to therapy . Int J Mol Med. 1998;2:143-148.
6.
Holmes DR Jr, Vliestra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty: a report from the PTCA registry of the National Heart, Lung and Blood Institute. Am J Cardiol. 1984 ;53:77C-81C.
7.
McBride W., Lange RA, Hillis LDRestenosis after successful coronary angioplasty. N Engl J Med. 1988; 318:1734-1737.
8.
Leimgruber PP , Roubin GS, Hollman J., et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation . 1986;73:710-717.
9.
Guiteras Val P., Bourassa MG, David PR, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience . Am J Cardiol.1987;60 (suppl):50B-55B.
10.
Asahara T., Bauters C., Pastore C., et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 1995; 91:2793-2801.
11.
Harker LA, Slichter SJ, Scott CR, et al. Homocystinemia: vascular injury and arterial thrombosis. N Engl J Med. 1974;291:537-543.
12.
Serrano C., Ramires J., Venturinelli M., et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecules expression: evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol. 1997 ;29:1276-1283.
13.
Kastrati A. , Koch W., Berger PB, et al. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol . 2000;36:2168-2173.
14.
Danenberg HD , Welt FGP , Walker M. III, et al. Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation. 2002;105:2917-2922.
15.
Ross R.Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-126.
16.
Griendling KK, Sorescu D., Lassegue B., Ushio-Fukai M.Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscl Thromb Vasc Biol. 2000;20:2175-2183.
17.
Brown MR, Miller FJ Jr, Li WG, et al. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular SMCs. Circ Res. 1999;85:524-533.
18.
Nishio E., Watanabe Y.The involvement of reactive oxygen species and arachidonic acid in α1-adrenoceptor-induced SMC proliferation and migration. Br J Pharmacol. 1997; 121:665-670.
19.
Cushing SD, Berliner JA, Valente AJ, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and SMCs. Proc Natl Acad Sci USA. 1990;87:5134-5138.
20.
Li D., Mehta JLAntisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation. 2000 ;101:2889-2895.
21.
Sawamura T. , Kume N., Aoyama T., et al. An endothelial receptor for oxidized low density lipoprotein. Nature. 1997;386:73-77.
22.
Kume N., Kita T.Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in atherogenesis . Trends Cardiovasc Med. 2001;11:22-25.
23.
Mehta JL, Li D.Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. J Am Coll Cardiol. 2002 ;39:1429-1435.
24.
Nagase M., Ando K., Nagase T., Kaname S., Sawamura T., Fujita T.Redox-sensitive regulation of lox-1 gene expression in vascular endothelium . Biochem Biophys Res Commun. 2001;281:720-725.
25.
Muscoli C., Sacco I., Alecce W., et al. The protective effect of superoxide dismutase mimetic M40401 on balloon injury-related neointima formation: role of lectin-like oxidized low-density lipoprotein receptor-1. J Pharmacol Exp Ther. 2004;311:44-50.
26.
Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DNNatural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities . Curr Pharm Des. 2004;10:3813-3833.
27.
Kris-Etherton PM, Hecker KD, Bonanome A., et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer . Am J Med.2002;113(suppl)9B:71S-88S.
28.
Gattuso G., Barreca D., Caristi C., Gargiulli C., Leuzzi U.Distribution of flavonoids and furocoumarins in juices from cultivars of Citrus Bergamia Risso. J Agric Food Chem. 2007;55(24):9921-9927.
29.
Dugo P., Mondello L., Dugo L., et al. LC-MS for the identification of oxygen heterocyclic compounds in citrus essential oils. J Pharm Biomed Anal. 2000;24:147-154.
30.
Dugo P., Presti ML, Ohman M., et al. Determination of flavonoids in citrus juices by micro-HPLC-ESI/MS . J Sep Sci. 2005;28:1149-1156.
31.
Corasaniti MT, Maiuolo J., Maida S., et al. Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA-induced cell death in vitro. Br J Pharmacol . 2007;151:518-529.
32.
Nagase M., Abe J., Takahashi K., et al. Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene. J Biol Chem. 1998;273:33702-33707.
33.
Kume N., Murase T., Moriwaki H., et al. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res. 1998 ;83:322-327.
34.
Aoyama T., Fujiwara H., Masaki T., Sawamura T.Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells. J Mol Cell Cardiol. 1999;31:2101-2114.
35.
Kunsch C., Medford RMOxidative stress as a regulator of gene expression in the vasculature . Circ Res. 1999; 85:753-766.
36.
Hinagata J. , Kakutani M., Fujii M., et al. Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model. Cardiovas Res. 2006 ;69:263-271.
37.
Li D., Williams V., Chen H., Sawamura T., et al. Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol. 2003;41(6):1048-1055.
38.
Cominacini L., Pasini AF, Garbin U., et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem. 2000 ;275:12633-12638.
39.
Li D., Romeo F., Mehta JLOxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Circulation. 2000;102: 1970-1976.
